Bio-Rad Laboratories Class A
BIO
BIO
301 hedge funds and large institutions have $4.58B invested in Bio-Rad Laboratories Class A in 2017 Q4 according to their latest regulatory filings, with 57 funds opening new positions, 101 increasing their positions, 101 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
0% more repeat investments, than reductions
Existing positions increased: 101 | Existing positions reduced: 101
0.33% less ownership
Funds ownership: 78.22% → 77.89% (-0.33%)
74% less call options, than puts
Call options by funds: $2.1M | Put options by funds: $8.14M
Holders
301
Holding in Top 10
7
Calls
$2.1M
Puts
$8.14M
Top Buyers
| 1 | +$51.2M | |
| 2 | +$29.8M | |
| 3 | +$24.9M | |
| 4 |
PC
Polar Capital
London,
United Kingdom
|
+$23.3M |
| 5 |
Millennium Management
New York
|
+$22.7M |
Top Sellers
| 1 | -$61.3M | |
| 2 | -$46.2M | |
| 3 | -$40.8M | |
| 4 |
ACM
Atlanta Capital Management
Atlanta,
Georgia
|
-$24.1M |
| 5 |
NFA
Nationwide Fund Advisors
Columbus,
Ohio
|
-$21.4M |